Three things to know:
1. Seven years of clinical results and data as well as 17,000 implants supported the decision.
2. The implant features cobalt chrome femoral and tibial components.
3. Implanet employs 38 staff and recorded $6.7 million in sales in 2018.
More articles on devices:
Orthofix reports $40.5M net loss in Q3, Jon Serbousek to become CEO: 5 details
New York orthopedic center to introduce robot for total knee replacements
California court tosses portion of labor suit against Zimmer Biomet — 4 insights
